HEALTH NEWS

Study Title:

Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk b

Study Abstract

Fisetin as a Senotherapeutic Agent: Biopharmaceutical Properties and Crosstalk between Cell Senescence and Neuroprotection. 

Study Information

Molecules. 2022 Jan 23;27(3):738. doi: 10.3390/molecules27030738. PMID: 35164003; PMCID: PMC8839434. 

Full Study

https://pubmed.ncbi.nlm.nih.gov/35164003/
September Sale

NOVEMBER SALE

Strengthen your immune health naturally!